The Total Return for Revvity (NYSE:RVTY) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
Notable Healthcare Headlines for the Week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in Focus
Maryland Rep. April McClain Delaney Sold Over $54K Worth of A.O. Smith Stock: Here's What You Should Know
Revvity Expands Alliance With Genomics England
These 4 Measures Indicate That Revvity (NYSE:RVTY) Is Using Debt Reasonably Well
KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating
Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively
What Does the Market Think About Revvity?
Revvity Says Euroimmun Gets CE Mark for Measles Antibody Detection
Revvity's EUROIMMUN Receives CE Mark For Measles Antibody Detection Assay
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
Investors Interested In Revvity, Inc.'s (NYSE:RVTY) Earnings
Express News | Revvity Inc Files for Mixed Shelf Offering; Size Not Disclosed- SEC Filing
Revvity Full Year 2024 Earnings: In Line With Expectations
Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?
Revvity | 10-K: FY2024 Annual Report
Massachusetts Court Grants Permanent Injunction To Revvity Against Cloud Software Over Spotfire
Express News | Revvity Wins Permanent Injunction Enforcing Agreements With Cloud Software Group
Revvity to Present at Upcoming Investor Conferences
Bretton Fund: "Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years"